A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 1.4B | 1.4B | 1.4B | 1.3B | 1.4B | 1.1B |
| Net Income | 77M | 77M | -46M | 26M | 95M | 53M |
| EPS | $0.62 | $0.62 | $-0.36 | $0.20 | $0.74 | $0.41 |
| Free Cash Flow | 212M | 212M | 145M | 117M | 206M | 150M |
| ROIC | 19.2% | 9.2% | -1.1% | 2.4% | 8.7% | 5.5% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.97 | 1.17 | 0.96 | 0.73 | 0.85 |
| Dividends/Share | $0.33 | $0.32 | $0.30 | $0.29 | $0.33 | $0.15 |
| Operating Income | 125M | 125M | -16M | 36M | 130M | 77M |
| Operating Margin | 8.7% | 8.7% | -1.1% | 2.7% | 9.5% | 6.8% |
| ROE | 13.1% | 13.1% | -8.2% | 4.1% | 13.2% | 8.0% |
| Shares Outstanding | 126M | 126M | 128M | 128M | 128M | 127M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.1B | 1.4B | 1.3B | 1.4B | 1.4B | 1.4B |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 77M | 130M | 36M | -16M | 125M | 125M |
| Op. Margin | 6.8% | 9.5% | 2.7% | -1.1% | 8.7% | 8.7% |
| Net Income | 53M | 95M | 26M | -46M | 77M | 77M |
| Net Margin | 4.6% | 7.0% | 1.9% | -3.3% | 5.4% | 5.4% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | 5.5% | 8.7% | 2.4% | -1.1% | 9.2% | 19.2% |
| ROE | 8.0% | 13.2% | 4.1% | -8.2% | 13.1% | 13.1% |
| ROA | 3.4% | 5.6% | 1.6% | -3.0% | 5.1% | 5.1% |
| Cash Flow | ||||||
| Op. Cash Flow | 165M | 230M | 148M | 171M | 242M | 242M |
| Free Cash Flow | 150M | 206M | 117M | 145M | 212M | 212M |
| Owner Earnings | 60M | 122M | 6.3M | -39M | 127M | 127M |
| CapEx | 15M | 25M | 32M | 27M | 29M | 29M |
| Maint. CapEx | 105M | 108M | 142M | 210M | 115M | 115M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 105M | 108M | 142M | 210M | 115M | 115M |
| CapEx/OCF | 9.0% | 10.8% | 21.4% | 15.6% | 12.2% | 12.2% |
| Capital Allocation | ||||||
| Dividends Paid | 19M | 39M | 37M | 38M | 41M | 41M |
| Dividend Yield | 1.3% | 2.3% | 2.9% | 3.7% | 3.4% | 3.7% |
| Share Buybacks | 0 | 13M | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||
| Net Debt | 470M | 476M | 558M | 615M | 503M | -70M |
| Cash & Equiv. | 89M | 45M | 42M | 41M | 70M | 70M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.85 | 0.73 | 0.96 | 1.17 | 0.97 | 0.00 |
| Interest Coverage | 6.3 | 11.1 | 3.3 | -0.6 | 4.1 | 4.1 |
| Equity | 656M | 719M | 623M | 560M | 592M | 592M |
| Total Assets | 1.6B | 1.7B | 1.6B | 1.5B | 1.5B | 1.5B |
| Total Liabilities | 907M | 991M | 934M | 982M | 919M | 919M |
| Intangibles | 898M | 1.0B | 926M | 1.0B | 985M | 985M |
| Retained Earnings | 98M | 158M | 127M | 47M | 84M | 84M |
| Working Capital | -143M | -266M | -134M | -117M | -120M | -120M |
| Current Assets | 206M | 204M | 200M | 209M | 225M | 225M |
| Current Liabilities | 348M | 470M | 334M | 326M | 345M | 345M |
| Per Share Data | ||||||
| EPS | 0.41 | 0.74 | 0.20 | -0.36 | 0.62 | 0.62 |
| Owner EPS | 0.47 | 0.96 | 0.05 | -0.31 | 1.01 | 1.01 |
| Book Value | 5.16 | 5.63 | 4.85 | 4.38 | 4.71 | 4.71 |
| Cash Flow/Share | 1.24 | 1.59 | 1.31 | 1.29 | 1.53 | 1.53 |
| Dividends/Share | 0.15 | 0.33 | 0.29 | 0.30 | 0.32 | 0.33 |
| Shares Out. | 127.2M | 127.6M | 128.4M | 127.9M | 125.8M | 125.8M |
| Valuation | ||||||
| P/E Ratio | 29.8 | 16.9 | 33.0 | -24.0 | 17.7 | 14.2 |
| P/FCF | 10.4 | 7.8 | 7.3 | 7.6 | 6.5 | 5.2 |
| EV/EBIT | 26.4 | 16.0 | 39.4 | N/A | 14.9 | 8.2 |
| Price/Book | 2.4 | 2.2 | 1.4 | 2.0 | 2.3 | 1.9 |
| Price/Sales | 1.4 | 1.2 | 0.6 | 0.8 | 0.9 | 0.8 |
| FCF Yield | 9.6% | 12.8% | 13.7% | 13.2% | 15.5% | 19.3% |
| Market Cap | 1.6B | 1.6B | 849M | 1.1B | 1.4B | 1.1B |
| Avg. Price | 11.31 | 13.44 | 10.12 | 8.16 | 9.70 | 8.76 |
| Year-End Price | 12.32 | 12.55 | 6.61 | 8.59 | 10.88 | 8.76 |
Terveystalo Plc passes 3 of 9 quality checks, indicating weak fundamentals.
Terveystalo Plc trades at 14.2x trailing earnings, compared to its 15-year median P/E of 23.7x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 5.2x vs a median of 7.6x. The company's 5-year average ROIC is 4.9%. Total shareholder yield (dividends) is 3.7%. At current prices, the estimated annualized return to fair value is +3.5%.
Terveystalo Plc (TTALO-HE) has a current P/E ratio of 14.2, compared to its historical median P/E of 23.7. The stock is currently considered Cheap based on its historical valuation range.
Terveystalo Plc (TTALO-HE) has a 5-year average return on invested capital (ROIC) of 4.9%. This is below average and may indicate limited pricing power.
Terveystalo Plc (TTALO-HE) has a market capitalization of $1.1B. It is classified as a small-cap stock.
Yes, Terveystalo Plc (TTALO-HE) pays a dividend with a trailing twelve-month yield of 3.73%.
Based on historical P/E analysis, Terveystalo Plc (TTALO-HE) appears cheap. The current P/E of 14.2 is 40% below its historical median of 23.7. The estimated fair value CAGR (P/E method) is -2.6%.
Terveystalo Plc (TTALO-HE) reported annual revenue of $1.4 billion in its most recent fiscal year, based on SEC EDGAR filings.
Terveystalo Plc (TTALO-HE) has a net profit margin of 5.4%. This is a modest margin.
Terveystalo Plc (TTALO-HE) generated $212 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Terveystalo Plc (TTALO-HE) has a debt-to-equity ratio of 0.97. This indicates moderate leverage.
Terveystalo Plc (TTALO-HE) reported earnings per share (EPS) of $0.62 in its most recent fiscal year.
Terveystalo Plc (TTALO-HE) has a return on equity (ROE) of 13.1%. This indicates moderate shareholder returns.
The Ledger Terminal provides 5 years of financial data for Terveystalo Plc (TTALO-HE), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Terveystalo Plc (TTALO-HE) has a book value per share of $4.71, based on its most recent annual SEC filing.
No recent press releases.